in vitro and in vivo immunologic parameters were determined in 26 patients treated continuously with cyclosporine to prevent graft-versus-host-disease ( gvhd ) after allogeneic bone marrow transplantation ( bmt ) for acute and chronic leukemia and for aplastic anemia .
C0010592
cyclosporine
C0018133
graft-versus-host-disease